Construction of Exosomes that Overexpress CD47 and Evaluation of Their Immune Escape

Abstract

Our general purpose was to provide a theoretical and practical foundation for the use of exosomes (EXOs) that have high levels of CD47 as stable and efficient drug carriers. Thus, we prepared EXOs from adipose tissue-derived mesenchymal stromal cells (ADMSCs) that had high levels of CD47 (EXOsCD47) and control EXOs (without CD47), and then compared their immune escape in vivo and their resistance to phagocytosis in vitro. Nanoflow cytometry was used to determine the CD47 level in these EXOs, and the amount of EXOsCD47 that remained in rat plasma at 3 h after intraperitoneal injection. Phagocytosis of the EXOs was also determined using in vitro rat macrophage bone marrow (RMA-BM) experiments. Our in vitro results showed that macrophages ingested significantly more control EXOs than EXOsCD47 (p < 0.01), with confirmation by ultra-high-definition laser confocal microscopy. Consistently, our in vivo results showed that rats had 1.377-fold better retention of EXOsCD47 than control EXOs (p < 0.01). These results confirmed that these engineered EXOsCD47 had improved immune escape. Our results therefore verified that EXOsCD47 had increased immune evasion relative to control EXOs, and have potential for use as drug carriers.

Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus

“…Exosomes are membrane derived nanoscale vesicles (30-150nm) that are released from different cell types under normal or pathological conditions and affect receptor cell activity by inducing signaling pathways. Exosomes vesicles carry various bioactive molecules (such as nucleic acids, proteins, and lipids) and participate in intercellular communication, as well as various physiological and pathological processes through various mechanisms [95]. Exosomes have unique advantages such as strong loading capacity, low immunogenicity, good penetration performance (including various physiological barriers such as Blood-brain barrier), good biocompatibility, biodegradability, and non-toxicity.…”

Extracellular Vesicles’ Role in Angiogenesis and Altering Angiogenic Signaling

“…Furthermore, EVs possess the ability to encapsulate substances, facilitating the targeted delivery of specific medications [ 103 , 104 ]. The presence of CD47, a “do not eat me signal”, on the exterior of EVs provides EVs an extra benefit, enabling them to acquire a tissue-healing capability and enhanced immune escape, thereby boosting their potential as vehicles for drug delivery [ 105 ]. Evidence from various fields of research has highlighted the potential of extracellular vesicles as promising therapeutic agents with significant clinical possibilities.…”

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine

“…Another advantage of natural exosomes as drug delivery systems is their optimal nanoscale size, which facilitates their penetration through biological barriers, such as the blood–brain barrier [ 129 ]. In addition, some subsets of exosomes are capable of evading immune recognition and clearance owing to the presence of the “self-marker” CD47 on their surface [ 130 ]. Evasion of immune surveillance increases exosomes’ duration of systemic circulation and protects their cargo from degradation [ 18 , 44 , 126 ].…”